Hagenbuchner, J., Rupp, M., Salvador, C., Meister, B., Kiechl-Kohlendorfer, U., Müller, T., . . . Ausserlechner, M. J. (2016). Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma. Oncotarget.
Stile di citazione ChicagoHagenbuchner, Judith, et al. "Nuclear FOXO3 Predicts Adverse Clinical Outcome and Promotes Tumor Angiogenesis in Neuroblastoma." Oncotarget 2016.
Citazione MLAHagenbuchner, Judith, et al. "Nuclear FOXO3 Predicts Adverse Clinical Outcome and Promotes Tumor Angiogenesis in Neuroblastoma." Oncotarget 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.